Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Delaware Healthcare Fund

+ Add to Watchlist

DLHAX:US

20.25 USD 0.13 0.65%

As of 09:29:30 ET on 03/04/2015.

Snapshot for Delaware Healthcare Fund (DLHAX)

Year To Date: +6.19% 3-Month: +4.22% 3-Year: +25.85% 52-Week Range: 16.50 - 20.27
1-Month: +4.49% 1-Year: +12.21% 5-Year: +20.50% Beta vs RGUSH: 0.91

Mutual Fund Chart for DLHAX

No chart data available.
  • DLHAX:US 20.25
  • 1M
  • 1Y
Interactive DLHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DLHAX

Delaware Healthcare Fund is an open-end fund incorporated in the USA. The Fund's objective is to maximize long-term capital growth through capital appreciation. The Fund invests at least 80% of its assets in the equity securities of health care companies.

Inception Date: 09-28-2007 Telephone: 1-800-523-1918
Managers: LIU-ER CHEN "NU"
Web Site: www.delawareinvestments.com/co/delaware

Fundamentals for DLHAX

NAV (on 2015-03-04) 20.25
Assets (M) (on 2015-03-04) 477.00
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 10.00

Dividends for DLHAX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-05) 0.01
Dividend Yield (ttm) 10.29

Fees & Expenses for DLHAX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 1.35

Top Fund Holdings for DLHAX

Filing Date: 12/31/2014
Name Position Value % of Total
Eli Lilly & Co 550,000 37,944,500 8.457%
Teva Pharmaceutical Industries 450,000 25,879,500 5.768%
Sanofi 283,794 25,873,632 5.766%
Bristol-Myers Squibb Co 341,737 20,172,735 4.496%
UCB SA 249,785 18,993,009 4.233%
Fresenius Medical Care AG & Co 230,000 17,166,478 3.826%
GlaxoSmithKline PLC 400,000 17,096,000 3.810%
Quest Diagnostics Inc 220,000 14,753,200 3.288%
Chugai Pharmaceutical Co Ltd 600,000 14,733,233 3.284%
SINA Corp/China 385,000 14,402,850 3.210%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil